Intezyne is continually evaluating potential partnering opportunities for the development of its products. We are actively collaborating with top academic institutions and industry professionals. We welcome inquiries from corporations, individuals, and academic institutions.
For more information on partnering with Intezyne, please contact us.
University of Notre Dame
Intezyne’s Research and Development Agreement with Notre Dame for pancreatic cancer is spearheaded by Dr. Reginald Hill, Archibald Assistant Professor of Cancer Biology, Biology of Pancreatic Cancer Initiation, Progression, and Chemoresistance
Nanotechnology Characterization Laboratory
Intezyne is collaborating with scientists at the Nanotechnology Characterization Laboratory on development of advanced analytical assays related to nanoparticle drug release profiles.